Antimony And Antimony Compounds
Antimony And Antimony Compounds releases at Nyacol Nanotechnologies INC rose from 9k lb to 72k lb (7.6×) between 2023 and 2024.
TRI facility · TRI 2024 reporting year
Nyacol Nanotechnologies INC
Total reported releases 72k lb more than doubled year over year (+125%). Total releases concentrations have more than doubled since 2010.
211 MEGUNKO RD, Ashland, Massachusetts · 325180 · Chemicals
Anomaly engine
Notable Signals
N511
N511 releases at Nyacol Nanotechnologies INC fell from 22k lb to 0 lb (100% lower) between 2023 and 2024.
Chemicals reported · most recent year
What This Facility Releases
Antimony And Antimony Compounds
Antimony And Antimony Compounds concentrations have more than doubled since 2010.
Lead And Lead Compounds
Lead And Lead Compounds concentrations have more than doubled since 2010.
Zinc compounds
Zinc compounds concentrations have more than halved since 2012.
Ethylene glycol
Ethylene glycol concentrations have more than halved since 2010.
Nitric acid
Nitric acid concentrations are roughly unchanged from 2010.
Equity context · ACS 2018-2022 block-group demographics
Who Lives Next To This Facility
Within 3 miles of this facility (24 Census block groups, population-weighted demographics): a population of 41,400. Why we surface this →
12.7%
Low-income
38.0%
People of color
6.1%
Under age 5
16.4%
Over age 64
Source: Census ACS 2018-2022 block-group demographics, population-weighted across the 3-mile buffer around this facility (from USEPA-clone/EJAM-open blockgroupstats). Indicator-level percentile and EJ-disparity scores are surfaced on the county page and the state page — they describe wider regional exposure burdens, not effects attributable to a single facility.
Source. EPA Toxics Release Inventory · retrieved 2026-05-07. Reporting year 2024. TRI is a federal public-domain dataset under 17 USC §105.
What this is not. TRI quantifies releases reported by the facility under EPCRA §313 — not ambient air or water concentrations measured at receptors. We do not attribute individual health outcomes to specific facilities; that exceeds what the data can support.